ストックスクリーナーアプリを入手
4.41
7.56%
0.31
アフターアワーズ：
4.44
0.03
+0.68%
Adc Therapeutics Sa (ADCT) 最新ニュース
ADC Therapeutics Amends HealthCare Royalty Financing Agreement - marketscreener.com
ADC Therapeutics Amends Royalty Deal, Issues New Warrants - TipRanks
ADC Therapeutics amends royalty deal with HealthCare Royalty By Investing.com - Investing.com Canada
Stepan Co recently released a project impact forecast, estimating that the cash impact over the entire project cycle will range between $29 million and $44 million, while the non-cash impact is expected to be between $58 million and $62 million. - Bitget
ADC Therapeutics SA (ADCT) recently released its performance outlook, expecting the company to enter a substantial growth phase starting in 2027. - Bitget
Healthcare Royalty Partners granted warrants to purchase approximately 9.8 million ordinary shares to ADC Therapeutics SA. - Bitget
ADC Therapeutics SA announced that, in the event of a change of control, the acquirer will continue to pay royalties to the healthcare royalty company until the originally agreed cap amount is reached. - Bitget
ADC Therapeutics announces amended Healthcare Royalty Financing agreement - marketscreener.com
ADC Therapeutics amends royalty deal with HealthCare Royalty - Investing.com
ADC Therapeutics grants warrants to Healthcare Royalty - Investing.com
ADC Therapeutics grants warrants to Healthcare Royalty By Investing.com - Investing.com UK
ADC Therapeutics Amends HCR Royalty Financing, Sets $150–$200 Million Change-of-Control Payment - TradingView
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement - PR Newswire
Analyst Calls: Is ADC Therapeutics SA affected by consumer sentimentWeekly Trade Recap & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Aug Patterns: Is CommScope Holding Company Inc stock undervalued right nowJuly 2025 Recap & Detailed Earnings Play Strategies - baoquankhu1.vn
ADCT SEC FilingsAdc Therapeutics Sa 10-K, 10-Q, 8-K Forms - Stock Titan
Has ADC Therapeutics (ADCT) outpaced other medical stocks this year? - MSN
ADC Therapeutics Announces Investigator-Initiated Study Abstract - GuruFocus
Will ADC Therapeutics SA stock sustain high P E ratiosMarket Activity Report & Risk Controlled Swing Trade Alerts - mfd.ru
What drives ADC Therapeutics SA’s stock priceJuly 2025 Setups & Growth Focused Investment Plans - mfd.ru
Can ADC Therapeutics SA stock deliver consistent earnings growth - mfd.ru
Can ADC Therapeutics SA stock outperform in 2025 bull marketEarnings Miss & Safe Capital Growth Stock Tips - mfd.ru
Will ADC Therapeutics SA stock hit new highs in YEARQuarterly Portfolio Report & Free Technical Confirmation Trade Alerts - mfd.ru
Analysts Set ADC Therapeutics SA (NYSE:ADCT) Price Target at $7.50 - Defense World
Bond Watch: Is ADC Therapeutics SA a stock for growth or value investorsGDP Growth & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5%Here's Why - MarketBeat
ADC Therapeutics (NYSE:ADCT) Trading Down 4.5%Here's What Happened - MarketBeat
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% – Here’s Why - Defense World
Little Excitement Around ADC Therapeutics SA's (NYSE:ADCT) Revenues - 富途牛牛
ADC Therapeutics SA's (NYSE:ADCT) Price Is Right But Growth Is Lacking - simplywall.st
Update On ADCs: Sales, Deals, Targets And Approvals - Citeline News & Insights
ADC Therapeutics Grants Stock Options to New Employees - Intellectia AI
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - Finviz
ADC Therapeutics (ADCT) upgraded to buy: Here's why - MSN
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan – Company Announcement - Financial Times
Growth Review: Can ADC Therapeutics SA continue delivering strong returns2025 Major Catalysts & Technical Pattern Recognition Alerts - baoquankhu1.vn
Is ADC Therapeutics SA stock a good dividend stockNew Guidance & High Accuracy Swing Entry Alerts - mfd.ru
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium - marketscreener.com
Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Can ADC Therapeutics SA expand its profit marginsTrade Entry Report & Long-Term Growth Stock Strategies - mfd.ru
Does ADC Therapeutics SA align with a passive investing strategyJuly 2025 Institutional & Capital Efficient Trading Techniques - mfd.ru
Will ADC Therapeutics SA benefit from sector rotation2025 Market Overview & Long-Term Investment Growth Plans - mfd.ru
Moving Averages: Why is ADC Therapeutics SA stock going upStock Surge & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Risk Off: Is ADC Therapeutics SA stock showing strong momentumPortfolio Gains Report & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Weekly Trades: Can ADC Therapeutics SA continue delivering strong returnsLayoff News & Verified Entry Point Detection - mfd.ru
Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SAADCT - PR Newswire
ADC Therapeutics Faces Securities Fraud Investigation, Stock Drops 14.13% - intellectia.ai
Breakouts Watch: Will ADC Therapeutics SA benefit from sector rotationWeekly Stock Report & Growth Oriented Trade Recommendations - baoquankhu1.vn
Insider Trends: Can ADC Therapeutics SA disrupt its industryQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
Is ADC Therapeutics SA stock attractive for retirement portfoliosWeekly Gains Report & Real-Time Volume Surge Alerts - bollywoodhelpline.com
Short Interest in ADC Therapeutics SA (NYSE:ADCT) Drops By 47.2% - MarketBeat
ADCT: Zynlonta's pivotal trials aim to transform its market reach and drive major growth from 2027 - TradingView
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - sharewise.com
Bull Bear: Why ADC Therapeutics SA stock could benefit from AI revolution2025 Risk Factors & Weekly High Momentum Picks - Bộ Nội Vụ
2.25%
0.47%
大文字化:
|
ボリューム (24 時間):